Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00110227 · ClinicalTrials.gov registry record · Phase 3
Tai Chi Mind-Body Therapy for Chronic Heart Failure
A Phase 3 study of Heart Failure, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT00110227: Completed Phase 3 study of Heart Failure, sponsored by Beth Israel Deaconess Medical Center.
NCT00110227 is a Phase 3 study of Heart Failure that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00110227, a Phase 3 study of Heart Failure, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.
Conditions Studied
Interventions
- BEHAVIORAL 12-week Tai Chi Program
- BEHAVIORAL 12-week Education Program
Study Locations (4)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center, Harvard Medical School - Boston
- Brigham and Women's Hospital - Boston
- Lown Cardiovascular Center - Brookline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
What the finished NCT00110227 record still lists
NCT00110227 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which 12-week Tai Chi Program is the first listed.
NCT00110227 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00110227 about?
NCT00110227 is a clinical study titled "Tai Chi Mind-Body Therapy for Chronic Heart Failure". The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.
What is the current status of trial NCT00110227?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2005-09. Estimated completion is 2009-07.
What conditions does trial NCT00110227 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT00110227?
The interventions under investigation include: 12-week Tai Chi Program (BEHAVIORAL), 12-week Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00110227?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00110227 being conducted?
This trial has 4 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00110227's enrollment target sits among peer trials
100 212th of 397 higher than 177 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Home-based Cardiac Rehabilitation in Heart Failure
RECRUITING · Phase 3
-
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
RECRUITING · Phase 3
-
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RECRUITING · Phase 3
-
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RECRUITING · Phase 3
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia